Last updated: August 3, 2021
Sponsor: William Beaumont Hospitals
Overall Status: Terminated
Phase
N/A
Condition
Cardiovascular Disease
Thrombosis
Myocardial Ischemia
Treatment
N/AClinical Study ID
NCT02953613
2015-129
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with stable ischemic heart disease or ACS undergoing cardiac catheterizationand possible PCI of a culprit lesion
- The study patient or the study patient's legal representative has been informed of thenature of the study, agrees to its provisions and has provided written informedconsent approved by the Institutional Review Board.
- The study patient agrees to comply with all required post-procedure follow up.
- Patient age 18-89 years old
Exclusion
Exclusion Criteria:
- STEMI within the prior 24 hours
- Cardiogenic shock or hypotension needing inotropes or hemodynamic support device
- Intra-procedural complication (perforation or a complication that would necessitateimmediate-unplanned revascularization) during index PCI procedure
- History of CABG
- Subject life expectancy less than 2 years at time of index catheterization
- Pregnant or unknown pregnancy status
- Psychological unsuitability or extreme claustrophobia
- Currently participating in another investigational cardiac device study. Note: Trialsrequiring extended follow-up for products that were investigational, but have sincebecome commercially available, are not considered investigational trials
- Inability to tolerate beta blockers
- Atrio-ventricular block (grade II-III), prolonged QT interval or sick sinus syndrome
- Renal insufficiency (creatinine ≥ 1.6 and/or, GFR < 60 ml/min) or renal failurerequiring dialysis
Study Design
Total Participants: 7
Study Start date:
April 28, 2016
Estimated Completion Date:
November 20, 2017
Study Description
Connect with a study center
William Beaumont Hospital
Royal Oak, Michigan 48073
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.